CORMORANT ASSET MANAGEMENT, LP – BridgeBio Pharma, Inc. Transaction History
CORMORANT ASSET MANAGEMENT, LP portfolio value:
$14.60M
portfolio value
CORMORANT ASSET MANAGEMENT, LP quarter portfolio value change:
+9.47%
quarter
BridgeBio Pharma, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 1.26M | $9.94 | 1.46M | |
| Q2 2022 | share | Decrease | -6.36% | -99.73K shares | -2.58M | $9.08 | 1.46M |
| Q1 2022 | share | Decrease | -5.99% | -100K shares | -11.91M | $10.15 | 1.56M |
| Q4 2021 | share | Decrease | -5.65% | -100K shares | -55.07M | $14.55 | 1.66M |
| Q3 2021 | share | Decrease | -5.96% | -112.07K shares | -31.75M | $46.87 | 1.76M |
| Q2 2021 | share | Decrease | -13.28% | -287.92K shares | -18.94M | $60.96 | 1.88M |
| Q1 2021 | share | Decrease | -4.27% | -96.85K shares | -27.51M | $61.6 | 2.16M |
| Q4 2020 | share | 0.00% | 0 shares | 76.10M | $71.11 | 2.26M | |
| Q3 2020 | share | Decrease | -12.54% | -325K shares | 526K | $37.52 | 2.26M |
| Q2 2020 | share | Decrease | -12.18% | -359.23K shares | -1.06M | $32.61 | 2.59M |
| Q1 2020 | share | Increase | +17.40% | 437.13K shares | -2.52M | $29 | 2.95M |
| Q4 2019 | share | Decrease | -4.00% | -104.70K shares | 31.87M | $35.05 | 2.51M |
| Q3 2019 | share | Decrease | -5.87% | -163.31K shares | -18.80M | $21.47 | 2.61M |
| Q2 2019 | share | Increase | 0.00% | 2.78M shares | 75M | $26.97 | 2.78M |